Educational explainer
Your tumor, your vaccine
Every cancer rewrites its own DNA as it grows. Those typos exist nowhere else in the body — which makes them the one thing that is unmistakably tumor and not you. This is how you turn them into a vaccine, and what the evidence so far actually shows.
The idea
Cancer cells carry a fingerprint no healthy cell has
As a tumor grows it copies its DNA over and over, and it makes mistakes. Most of those mistakes do nothing. Some change the shape of a protein. Those changed proteins are called , and they are the only thing that marks a cancer cell as foreign.
Your immune system already patrols for foreign things. The problem is that it has never been shown what to look for, and the tumor is actively telling it to stand down. A personalized vaccine fixes the first problem. A second drug fixes the second.
Step one
Turning a typo into a wanted poster
Every cell constantly shreds its own proteins into short fragments and holds them up on its surface, like a shop displaying samples of everything inside. Passing inspect those samples. If a fragment looks wrong, the cell gets destroyed.
So a vaccine's job is to pick the fragments that span a mutation — the ones that look wrong — and teach the immune system their faces in advance.
Why it has to be personal
Your body can only display certain fragments
The molecules that hold fragments up for inspection are called , and yours are different from almost everyone else's. An HLA molecule is a particular shape, and it can only grip fragments that fit it. A mutation nobody in your body can display is useless as a target, however dramatic it looks in the DNA.
So the vaccine depends on two things: which mutations your tumor has, and which fragments your body can show. Here is the same tumor run against three different sets of common HLA types.
Step two
From every mutation down to thirty-four
Most candidates do not survive. This is the real narrowing, run on a public, de-identified melanoma sample. Hover or tap any step to see exactly what was discarded and why — the discards are the honest part.
Step three
Ranking what is left
Four questions decide the order. Move the sliders to weigh them differently and the ranking updates immediately — it is the same arithmetic the pipeline runs.
Step four
Writing them into one message
The chosen fragments get strung together into a single strand of — an instruction sheet. Your own cells read it, build the fragments, and display them. The immune system learns the faces without anyone ever having to inject a tumor.
The part that matters
Does it actually work?
A trial called KEYNOTE-942 gave 157 people with melanoma either this vaccine plus an antibody called pembrolizumab, or the antibody alone, after surgery removed their tumors. Then it waited five years to see who had a recurrence.
Out of 100 people like this…
Percentages are slippery. Here is the same result as people. Each figure is one person; coloured figures are still cancer-free at the timepoint you choose.
What this does and does not prove
The caveats are the point
This is a promising result from a small trial, and it is not proof. Every one of these is a real limitation of the evidence, not a disclaimer bolted on afterwards.
The bottom line
Check it yourself
Every number here is reproducible
The patient-level data behind that curve was rebuilt from the trial's own published summary table. Here is how closely the reconstruction lands on what was actually published — including where it does not.